Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | KLKB1 | P03952 | 4/20 | 0.33 |
| ▸ | DGAT2 | Q96PD7 | 2/20 | 0.32 |
| ▸ | DHODH | Q02127 | 2/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.32 |
| ▸ | SLC2A3 | P11169 | 2/20 | 0.32 |
| ▸ | SLC2A4 | P14672 | 2/20 | 0.32 |
| ▸ | SLC2A2 | P11168 | 1/20 | 0.32 |
| ▸ | CCR1 | P32246 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10089892 | 0.93 | DHODH (0.38) | PPARGIDH1KLKB1DHODHMMP13 | |
| SCHEMBL10089870 | 0.93 | KMT2A (0.36) | PPARGIDH1KLKB1DHODHMMP13 | |
| SCHEMBL10089931 | 0.93 | SLC2A1 (0.36) | IDH1KLKB1NR3C1SLC2A1SLC2A3 | |
| SCHEMBL10089874 | 0.92 | MMP13 (0.36) | PPARGIDH1DGAT2DHODHMMP13 | |
| SCHEMBL10089876 | 0.92 | PPARG (0.36) | PPARGMMP13NR3C1CCR1 | |
| SCHEMBL10089858 | 0.92 | IDH1 (0.40) | PPARGIDH1DHODHMMP13CCR1 | |
| SCHEMBL10089967 | 0.92 | DHODH (0.36) | PPARGIDH1DHODHMMP13 | |
| SCHEMBL10090027 | 0.92 | PPARG (0.34) | PPARGIDH1KLKB1DHODHMMP13 | |
| SCHEMBL10089981 | 0.91 | IDH1 (0.36) | PPARGIDH1DHODHMMP13 | |
| SCHEMBL10090043 | 0.91 | MMP13 (0.38) | PPARGKLKB1MMP13CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791143-B2 | Anthranilic diamide derivatives having cyclic side-chains | BAYER CROPSCIENCE AG (DE) | 2014-07-29 | — | — | US | disclosed |
| US-20120010249-A1 | Anthranilic diamide derivatives having cyclic side-chains | BAYER CROPSCIENCE AG (DE) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010249-A1 | Anthranilic diamide derivatives having cyclic side-chains | DDT, ADCY1, ANTXR2 | PPARG 3227/4885IDH1 99/4885KLKB1 4458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.